Modiodal (Modafinil)

Modafinil, the active ingredient in Modiodal, is a eugeroic presented as an oral formulation for oral use. It promotes wakefulness in patients with narcolepsy, obstructive sleep apnea, and shift work sleep disorder.

GNH USA supplies Modiodal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Modiodal is a central nervous system stimulant indicated for sleep‑related disorders.

Narcolepsy: reduces excessive daytime sleepiness and improves alertness. Obstructive sleep apnea: helps maintain wakefulness in patients receiving standard therapy. Shift work sleep disorder: alleviates sleepiness during scheduled work hours.

Modiodal may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache - Nausea - Insomnia - Anxiety - Dry mouth - Diarrhea

Serious or Rare Side Effects: - Severe rash or Stevens‑Johnson syndrome - Psychiatric symptoms such as hallucinations or mania - Cardiovascular events including hypertension or arrhythmia - Hepatic dysfunction - Allergic reactions with swelling or difficulty breathing

Before prescribing Modiodal, consider the following safety measures.

Assess cardiovascular status: evaluate blood pressure and heart rate prior to initiation. Review psychiatric history: monitor for emergence of anxiety, depression, or psychosis. Consider hepatic function: adjust use in patients with liver impairment. Avoid abrupt discontinuation: taper under medical supervision to reduce rebound sleepiness. Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Modiodal can interact with several medication classes; awareness of interaction severity is essential.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations. - CYP3A4 inducers (e.g., rifampicin): may reduce therapeutic effect. - Oral contraceptives: may decrease contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antidepressants (especially SSRIs): monitor for heightened side effects. - Antihypertensives: observe blood pressure for potential changes. - Anticoagulants: watch for altered bleeding risk.